Clinica BavieraXMAD:CBAV -0.36%99 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates XMAD:CBAV with a GF Score™ of 99/100 and a GF Value™ of €41.30 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Clinica Baviera ranks worse than 526315.26% on this metric.
The historical rank and industry rank for Clinica Baviera's Days Payable or its related term are showing as below:
During the past 13 years, Clinica Baviera's highest Days Payable was 228.06. The lowest was 188.58. And the median was 206.08.
XMAD:CBAV's Days Payable is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 67.275 * Ranked among companies with meaningful Days Payable only.
Clinica Baviera's Days Payable
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
stayed the same
Clinica Baviera Days Payable Related Terms
Clinica Baviera Days Payable Historical Data
* Premium members only.
The historical data trend for Clinica Baviera's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:CBAV vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Clinica Baviera's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinica Baviera Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's Days Payable distribution charts can be found below:
* The bar in red indicates where Clinica Baviera's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Clinica Baviera's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinica Baviera (XMAD:CBAV) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clinica Baviera and its competitors. Over the past decade, Clinica Baviera's Days Payable has ranged from 188.58 to 228.06. According to the industry distribution chart, Clinica Baviera ranks #999999 out of 190 companies in the Medical Diagnostics & Research industry.
Is Clinica Baviera's Days Payable too high?
Clinica Baviera's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 188.58 to a high of 228.06. Based on the distribution chart, Clinica Baviera ranks #999999 out of 190 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Clinica Baviera has a GF Score™ of 99/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clinica Baviera ranks #999999 out of 190 companies for Days Payable. This places Clinica Baviera in the lower half of its industry. The industry median Days Payable is 67.28. Historically, Clinica Baviera's own Days Payable has ranged from 188.58 to 228.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 67.28, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clinica Baviera and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 67.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinica Baviera's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Based on GuruFocus' analysis, Clinica Baviera (XMAD:CBAV) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.30, compared to a current price of €55.20 — trading 33.7% above its estimated fair value. The current Days Payable is 0.00. Clinica Baviera's overall GF Score™ is 99/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Clinica Baviera (XMAD:CBAV), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?
Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued.
The current stock price of €55.20 is trading 33.7% above its estimated GF Value™ of €41.30.
GuruFocus considers Clinica Baviera to be Significantly Overvalued.
Key valuation signals for XMAD:CBAV:
Days Payable: 0.00
GF Value™: €41.30 vs. price of €55.20 (33.7% above fair value)
No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
99GF Score
Get the complete analysis for XMAD:CBAV
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:CBAV has been successfully added to your 
